Pena Luis C. bought EVMN

November 7, 2025 · Form 4 insider transaction

Pena Luis C. bought 24,225 shares of Evommune, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
24,225
Price
N/A
Total value
N/A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateNovember 7, 2025
Filing dateNovember 12, 2025
Shares owned after682,821
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each share of Series Seed Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-8.518 basis and had no expiration date.

View the original Form 4 on SEC EDGAR